54 results
Page 2 of 3
6-K
EX-99.1
831kg59 g6np002mpcgy
6 Aug 21
Amryt Reports Record Q2 2021 Results and Raises FY 2021 Guidance
8:18am
424B3
kzj37rz6tf4 0t8m
6 Aug 21
Prospectus supplement
8:17am
424B3
eda dy5gln
1 Jul 21
Prospectus supplement
5:20pm
F-4/A
ujqtyhj3 eqly8j
29 Jun 21
Registration of securities (foreign) (amended)
9:29am
F-4
j4vnvd9glhz1fztgrv6v
15 Jun 21
Registration of securities (foreign)
12:00am
424B3
x1gmi4dw9j
2 Jun 21
Prospectus supplement
10:10am
424B3
uh8ki3
2 Jun 21
Prospectus supplement
10:09am
424B3
0mjnibuye94c f9o
2 Jun 21
Prospectus supplement
10:08am
425
tze1ull h21o9ooeb3
5 May 21
Business combination disclosure
5:26pm
425
v1y1baoogx7ql29v
5 May 21
Business combination disclosure
5:25pm
425
foxrws oix59kdoa
5 May 21
Business combination disclosure
5:24pm
6-K
EX-99.5
n6gs7yte74gqpk
5 May 21
Agreement and Plan of Merger
5:19pm
6-K
EX-99.1
8m48lmpxwzjjsu3c
5 May 21
Amryt Reports Record Q1 2021 Financial and Operating Results
9:40am
6-K
EX-99.1
ibd5mk
5 May 21
Amryt Pharma to Acquire Chiasma, Inc. to Further Strengthen Global Leadership in Rare and Orphan Diseases
8:45am
20-F
28gytm 1s5lj
30 Apr 21
Annual report (foreign)
12:53pm
424B3
5nb0v2b
4 Mar 21
Prospectus supplement
8:38am
6-K
EX-99.1
b26w4x4
4 Mar 21
Amryt Announces Record FY 2020 Results
8:20am
424B4
e02a9lp35
14 Jan 21
Prospectus supplement with pricing info
9:30am
F-1/A
inct9kv2dqxic
12 Jan 21
Registration statement (foreign) (amended)
12:00am
F-1
xdliuvjc93yy71
8 Jan 21
Registration statement (foreign)
4:58pm